Jeffrey E. Russel

Array ( [id] => 8951409 [patent_doc_number] => 20130197190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'METHOD FOR PRODUCING SURFACTIN AND SALT THEREOF' [patent_app_type] => utility [patent_app_number] => 13/876734 [patent_app_country] => US [patent_app_date] => 2011-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6347 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876734 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209091 [patent_doc_number] => 20120128755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Personal Care Composition Containing Yeast Extract And Hexapeptide' [patent_app_type] => utility [patent_app_number] => 13/247689 [patent_app_country] => US [patent_app_date] => 2011-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4582 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128755.pdf [firstpage_image] =>[orig_patent_app_number] => 13247689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11296743 [patent_doc_number] => 09504736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-29 [patent_title] => 'Administration of serine protease inhibitors to the stomach' [patent_app_type] => utility [patent_app_number] => 13/825779 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5797 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8173595 [patent_doc_number] => 20120108520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'Antimicrobial Compounds and Formulations' [patent_app_type] => utility [patent_app_number] => 13/239662 [patent_app_country] => US [patent_app_date] => 2011-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21403 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108520.pdf [firstpage_image] =>[orig_patent_app_number] => 13239662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916788 [patent_doc_number] => 20130178413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'HCV NS3 PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/825245 [patent_app_country] => US [patent_app_date] => 2011-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25347 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10155767 [patent_doc_number] => 09187524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Broad spectrum antibiotic arylomycin analogs' [patent_app_type] => utility [patent_app_number] => 13/821195 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 68750 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663627 [patent_doc_number] => 20110312896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'INHIBITORS OF BCL-2' [patent_app_type] => utility [patent_app_number] => 13/218818 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14845 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312896.pdf [firstpage_image] =>[orig_patent_app_number] => 13218818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313585 [patent_doc_number] => 20120190610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'TETRANECTIN-APOLIPOPROTEIN A-I, LIPID PARTICLES CONTAINING IT AND ITS USE' [patent_app_type] => utility [patent_app_number] => 13/217534 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 28552 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13217534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662274 [patent_doc_number] => 20110311543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 13/215883 [patent_app_country] => US [patent_app_date] => 2011-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13879 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311543.pdf [firstpage_image] =>[orig_patent_app_number] => 13215883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8664428 [patent_doc_number] => 08377889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-19 [patent_title] => 'Adiponectin receptor fragments and methods of use' [patent_app_type] => utility [patent_app_number] => 13/211558 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 10006 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13211558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754521 [patent_doc_number] => 20120027718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'COMBINATION THERAPY WITH GLATIRAMER ACETATE AND RASAGILINE FOR THE TREATMENT OF MULTIPLE SCLEROSIS' [patent_app_type] => utility [patent_app_number] => 13/198229 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5192 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027718.pdf [firstpage_image] =>[orig_patent_app_number] => 13198229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757437 [patent_doc_number] => 20120029176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Chromatography Media And Method' [patent_app_type] => utility [patent_app_number] => 13/191992 [patent_app_country] => US [patent_app_date] => 2011-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17555 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029176.pdf [firstpage_image] =>[orig_patent_app_number] => 13191992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239835 [patent_doc_number] => 20120148571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'AMINO ACID SEQUENCES THAT BIND TO SERUM PROTEINS IN A MANNER THAT IS ESSENTIALLY INDEPENDENT OF THE PH, COMPOUNDS COMPRISING THE SAME, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/184955 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22403 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13184955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7767831 [patent_doc_number] => 20120035095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/180309 [patent_app_country] => US [patent_app_date] => 2011-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25418 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035095.pdf [firstpage_image] =>[orig_patent_app_number] => 13180309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898105 [patent_doc_number] => 08921319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Serine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 13/808524 [patent_app_country] => US [patent_app_date] => 2011-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14357 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9108236 [patent_doc_number] => 20130281368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'Glucagon-Like Peptide-1 Glycopeptides' [patent_app_type] => utility [patent_app_number] => 13/805461 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11153 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8977320 [patent_doc_number] => 20130210749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'PEPTIDES, CONSTRUCTS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/703115 [patent_app_country] => US [patent_app_date] => 2011-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 26614 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13703115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10648224 [patent_doc_number] => 09364449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same' [patent_app_type] => utility [patent_app_number] => 13/134547 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 19046 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13134547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7696181 [patent_doc_number] => 20110230409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'GLP-I Agonist And Cardiovascular Complications' [patent_app_type] => utility [patent_app_number] => 13/151618 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6070 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0230/20110230409.pdf [firstpage_image] =>[orig_patent_app_number] => 13151618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9648613 [patent_doc_number] => 08802624 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-12 [patent_title] => 'Methods of treatment using orodispersible desmopressin pharmaceutical formulations' [patent_app_type] => utility [patent_app_number] => 13/110619 [patent_app_country] => US [patent_app_date] => 2011-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9438 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13110619 [rel_patent_id] =>[rel_patent_doc_number] =>)